Home / Business News (page 20)

Business News

LegoChem and Takeda Partner for the Development of Antibody-Drug Conjugates in Immuno-Oncology

DAEJEON, South Korea–(BUSINESS WIRE)–LegoChem Biosciences, Inc. (“LCB”) (KOSDAQ:141080) announced today that it has entered a research collaboration and license agreement with Takeda Pharmaceutical Company Limited (“Takeda”) for the development of antibody-drug conjugates in immuno-oncology. Takeda gains certain rights to LCB’s antibody-drug conjugate (ADC) technology, ConjuAll, including LCB’s proprietary linker and conjugation …

Read More »

Celgene and Exscientia Enter AI Drug Discovery Collaboration Focused on Accelerating Drug Discovery in Oncology and Autoimmunity

Oxford, UK,21 March 2019: Exscientia, a world-leading Artificial Intelligence (AI)-driven drug discovery company, announced today that it has entered a three-year AI drug discovery partnership with leading biopharma company Celgene, including an initial $25 million upfront payment and eligibility to receive substantial milestones based on the clinical, regulatory and commercial …

Read More »

Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics

PARIS & NEW YORK–(BUSINESS WIRE)–Vivet Therapeutics (“Vivet”), a privately held gene therapy biotech company dedicated to developing gene therapy treatments for inherited liver disorders with high unmet medical need, and Pfizer Inc. (NYSE: PFE) announced today that Pfizer has acquired a 15% equity interest in Vivet and secured an exclusive option …

Read More »

Alexion and Affibody Announce Partnership to Co-Develop Anti-FcRn Affibody Molecule

BOSTON & SOLNA, Sweden–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Affibody AB today announced a partnership to co-develop ABY-039 for rare Immunoglobulin G (IgG)-mediated autoimmune diseases. Currently in Phase 1 development, ABY-039 is a bivalent antibody-mimetic that targets the neonatal Fc receptor (FcRn). ABY-039 has been specifically designed to combine Affibody’s protein …

Read More »

Merck Extends Strategic Collaboration with NGM Bio for Discovery and Development of Novel Biologic Therapeutics

KENILWORTH, N.J., and SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc. (NGM) today announced that Merck has exercised its option to extend the research phase of the companies’ broad, strategic collaboration for an additional two-year period from March 2020 …

Read More »

Merck KGaA Collaborates with Iktos for Generative Artificial Intelligence Technology

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced a collaboration agreement with Iktos, for the use of its generative modelling artificial intelligence (AI) technology, in order to facilitate the rapid and cost-effective discovery and design of promising new compounds. “This agreement is another illustration of how …

Read More »

AbCellera Signs Agreement with Global Health Foundation to Fight Infectious Disease

VANCOUVER, British Columbia–(BUSINESS WIRE)–AbCellera today announced a two-year agreement with the Bill & Melinda Gates Foundation to help accelerate global health research. The funding, totaling $4.8 M, will support a series of scientific collaborations between AbCellera and Gates Foundation-funded scientists working on the prevention and treatment of high-priority infectious diseases. The …

Read More »

BioLife Solutions Expands Cell and Gene Therapy Tools Portfolio with Acquisition of Astero Bio

BOTHELL, Wash., March 14, 2019 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife”) today announced that it has entered into an agreement to acquire Astero Bio Corporation (“Astero”), a privately-held innovator in the design, development and commercialization of novel automated thawing devices, for an upfront cash payment of $8.0 million. …

Read More »

Biocept Expands its Pathology Partnership Offering for Liquid Biopsy with the Addition of Several Key Services

SAN DIEGO, March 13, 2019 /PRNewswire/ — Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it has expanded its pathology partnership platform, EmpowerTCTM, to now offer local …

Read More »

Smith & Nephew to Acquire Osiris Therapeutics for $660 Million

COLUMBIA, Md., March 12, 2019 (GLOBE NEWSWIRE) — Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, today announced that it has entered into an agreement and plan of merger with Smith & Nephew plc pursuant to …

Read More »